As RT has been shown to have promising anti-cancer activity against lung cancer through its Mcl-1-targeted activity, as demonstrated in our previous study [23], we designated RT as a lead compound and generated simplified right-half models in order to elucidate the SAR. This evidence concerns the gene MCL1 and lung cancer.